30 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 15 MG/ML Injection
- RxCUI
- 1867996
- RxNorm name
- 30 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 15 MG/ML Injection
- Display name
- EPINEPHrine/Lidocaine (Injectable)
- Full name
- 30 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 15 MG/ML Injection
- Term type
- SCD
- Status
- Active
- Strength
- 0.005-15 mg/ml
- Dose form
- Injection 30 ml
- Route
- Injectable
- Updated
- 2026-10-26 03:56:41
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 032017
- Active start
- 032017
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| epinephrine bitartrate | 5 MCG / 1 ML | epinephrine | epinephrine |
| lidocaine hydrochloride | 15 MG / 1 ML | lidocaine | lidocaine hydrochloride |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Injection | 1649574 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| epinephrine | 3992 |
| lidocaine | 6387 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | 30 ML EPINEPHrine 0.005 MG/ML / lidocaine hydrochloride 15 MG/ML Injection | 1 | NAMES |
| RxNorm Name | 30 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 15 MG/ML Injection | 1 | NAMES |
| RxNorm Synonym | lidocaine HCl 1.5 % / EPINEPHrine 1:200,000 per 30 ML Injection | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 2f94f711-14c4-48ec-c5a3-c5ec4b8e8729 | 1 | CODES |
| RxCUI | 1867996 | 1 | CODES |
| MMSL_CODE | MTH_RXN_BD14948 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0409-3181-01 | 0409-3181 | Lidocaine Hydrochloride and Epinephrine LIDOCAINE HYDROCHLORIDE and EPINEPHRINE | Hospira, Inc. | ANDA089645 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA089645 | 0409-3181 | Lidocaine Hydrochloride and Epinephrine LIDOCAINE HYDROCHLORIDE and EPINEPHRINE | ANDA | Hospira, Inc. |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Xylocaine | LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | ba082c2f-64f4-419d-9c88-74f203316e17 | 2021-08-25 | Warnings, Adverse reactions | 1867996 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2f94f711-14c4-48ec-c5a3-c5ec4b8e8729 | lidocaine HCl 1.5 % / EPINEPHrine 1:200,000 in 30 ML Injection [PSN] · 30 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 15 MG/ML Injection [SCD] · lidocaine HCl 1.5 % / EPINEPHrine 1:200,000 per 30 ML Injection [SY] | 3 | 34 | These highlights do not include all the information needed to use LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION safely and effectively. See full prescribing information for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION. LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE 1:100,000 injection, for infiltration and nerve block LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE 1:200,000 injection, for infiltration and nerve block LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE 1:200,000 injection, for infiltration, nerve block, epid | 20260504 |
| ba082c2f-64f4-419d-9c88-74f203316e17 | lidocaine HCl 1.5 % / EPINEPHrine 1:200,000 in 30 ML Injection [PSN] · 30 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 15 MG/ML Injection [SCD] · lidocaine HCl 1.5 % / EPINEPHrine 1:200,000 per 30 ML Injection [SY] | 3 | 13 | Xylocaine® (lidocaine HCl Injection, USP) Xylocaine® (lidocaine HCl and epinephrine Injection, USP) | 20210825 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 08031cc0-168d-42d7-b6a9-ba2509a21714 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20161017 | |
| 0ff5394b-dde1-4e3c-9ceb-c8f06d8cff6f | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20161003 | |
| 1e2e47e1-09af-4d46-9354-2b01ec3efed9 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20160926 | |
| 16b64c7f-b70a-4192-b4b8-b0c941891c1d | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | 3M Company | 20160809 | |
| 191cd69c-3eb9-4ad1-94d0-6698fddc978d | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20160805 | |
| 1914d1e0-2a16-47d1-bf1b-f43622a2a3d0 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20160804 | |
| 01342e4f-7673-4c5e-857e-3fe52ecc4300 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20160615 | |
| 0d52ee7d-a955-4263-b53b-b697c3fa013d | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20150519 | |
| 03e5eb6f-165c-45a9-882d-439e409f6678 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20140624 | |
| 0669f746-bf9f-4d5d-a8cf-2155b7de8258 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20140411 | |
| 1d61e2b9-175b-4a55-a28d-6148a3b29f93 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20131211 | |
| 09abf090-af04-4381-963d-c88b93c82a21 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20130913 | |
| 0f4470d2-869b-4c57-b2ab-1f4646fbf3b3 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20130903 | |
| 1ad37787-3b83-46b4-b21b-921393376e87 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20130614 | |
| 07833fa7-ff72-44f0-b9e0-ed9f879f3289 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | 20130318 | |
| 1905221a-7612-406e-aebd-202302ca43ef | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20130124 | |
| ff91ff8c-defe-4a3d-b58f-1db1923ff50d | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20130121 | |
| 1335b50d-29f8-4792-9722-2da9924a6e5a | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20130118 | |
| 02b70048-d117-4ec1-af43-c48821479ab9 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20130118 | |
| 153cfb34-8d03-4912-a5c3-198c4cfb67a3 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20130104 | |
| 1c099757-264e-481a-a779-3bdb3e452b80 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20121217 | |
| 194f4d4a-9b35-48d1-bb91-bbe8cb0afa2f | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20121217 | |
| 005bfa1f-b9fd-4d63-a926-515d341667dd | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20121128 | |
| 2107d282-e496-4562-872a-bc86b123bed7 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20121128 | |
| 07bc452d-60fa-4878-a9ba-8424eff31da3 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20121127 | |
| 017ce5d8-c687-41d6-9e09-0574a7f430ff | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20121116 | |
| 0c6cb68a-559c-4f28-8a79-7f915582a589 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20121106 | |
| 12fb8567-776c-4349-8eec-813b79d48be7 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20121025 | |
| 0d895e4c-ec4d-47ff-b624-0df457e7bfc7 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20121011 | |
| 138e6620-94e4-4c3b-92da-77077b2dd0d3 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20121008 | |
| 0b8d5445-0ba8-4438-9396-ce6fa817229c | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20120924 | |
| 081f8334-5b72-429a-b7db-cf2dcc6e1337 | OBGYN Procedure Kit | Centurion Medical Products | Hospira Inc | 20120924 |
| 2056833d-707b-41e6-80af-357732da78e7 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20120924 | |
| 06c7a4e5-9da1-474c-ac35-61a98d0be3bb | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20120817 | |
| 1a1426f5-bad9-4ecf-b703-afcf62f040d7 | National Council for Prescription Drug Programs | 20120724 | |
| 14b387ce-d85c-4fa4-9a14-9812d64842a2 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20120525 | |
| 14224b96-2303-47c5-a71c-164bca22790d | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20120511 | |
| 06503b70-0091-4779-9ad0-8a2b48542b6e | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20120412 | |
| 181a5ebb-2ff4-4d51-b4f7-18e40141fa52 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | 20120326 | |
| 240f2ee1-9dd2-4ad3-b3b4-c13feae27af6 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20120321 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C01CA | Adrenergic and dopaminergic agents | ATC1-4 | epinephrine | |
| ATC | R03AA | Alpha- and beta-adrenoreceptor agonists | ATC1-4 | epinephrine | |
| ATC | N01BB | Amides | ATC1-4 | lidocaine | |
| ATC | S02DA | Analgesics and anesthetics | ATC1-4 | lidocaine | |
| ATC | D04AB | Anesthetics for topical use | ATC1-4 | lidocaine | |
| ATC | R02AD | Anesthetics, local | ATC1-4 | lidocaine | |
| ATC | C01BB | Antiarrhythmics, class Ib | ATC1-4 | lidocaine | |
| ATC | C05AD | Local anesthetics | ATC1-4 | lidocaine | |
| ATC | S01HA | Local anesthetics | ATC1-4 | lidocaine | |
| ATC | B02BC | Local hemostatics | ATC1-4 | epinephrine | |
| ATC | A01AD | Other agents for local oral treatment | ATC1-4 | epinephrine | |
| ATC | S01EA | Sympathomimetics in glaucoma therapy | ATC1-4 | epinephrine | |
| ATC | R01AA | Sympathomimetics, plain | ATC1-4 | epinephrine | |
| FDASPL | D002395 | Catecholamines | CHEM | has_chemical_structure | epinephrine |
| FDASPL | N0000175552 | alpha-Adrenergic Agonist | EPC | has_epc | epinephrine |
| FDASPL | N0000175682 | Amide Local Anesthetic | EPC | has_epc | lidocaine |
| FDASPL | N0000175426 | Antiarrhythmic | EPC | has_epc | lidocaine |
| FDASPL | N0000175555 | beta-Adrenergic Agonist | EPC | has_epc | epinephrine |
| FDASPL | N0000175570 | Catecholamine | EPC | has_epc | epinephrine |
| FDASPL | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | epinephrine |
| FDASPL | N0000000245 | Adrenergic beta-Agonists | MOA | has_moa | epinephrine |
| FDASPL | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine |
| MEDRT | D004837 | Epinephrine | CHEM | has_ingredient | epinephrine |
| MEDRT | D008012 | Lidocaine | CHEM | has_ingredient | lidocaine hydrochloride |
| MEDRT | D008012 | Lidocaine | CHEM | has_ingredient | lidocaine |
| MEDRT | D000219 | Adams-Stokes Syndrome | DISEASE | ci_with | lidocaine hydrochloride |
| MEDRT | D000219 | Adams-Stokes Syndrome | DISEASE | ci_with | lidocaine |
| MEDRT | D000402 | Airway Obstruction | DISEASE | may_treat | epinephrine |
| MEDRT | D000707 | Anaphylaxis | DISEASE | may_treat | epinephrine |
| MEDRT | D001145 | Arrhythmias, Cardiac | DISEASE | ci_with | epinephrine |
| MEDRT | D001919 | Bradycardia | DISEASE | may_treat | epinephrine |
| MEDRT | D001986 | Bronchial Spasm | DISEASE | may_treat | epinephrine |
| MEDRT | D002056 | Burns | DISEASE | may_treat | lidocaine |
| MEDRT | D002056 | Burns | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | epinephrine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | lidocaine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | lidocaine hydrochloride |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | lidocaine |
| MEDRT | D004935 | Esophageal Diseases | DISEASE | may_treat | lidocaine |
| MEDRT | D004935 | Esophageal Diseases | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D015812 | Glaucoma, Angle-Closure | DISEASE | ci_with | epinephrine |
| MEDRT | D005902 | Glaucoma, Open-Angle | DISEASE | may_treat | epinephrine |
| MEDRT | D006323 | Heart Arrest | DISEASE | may_treat | epinephrine |
| MEDRT | D006327 | Heart Block | DISEASE | may_treat | epinephrine |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | lidocaine hydrochloride |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | lidocaine |
| MEDRT | D007022 | Hypotension | DISEASE | may_treat | epinephrine |
| MEDRT | D009059 | Mouth Diseases | DISEASE | may_treat | lidocaine |
| MEDRT | D009059 | Mouth Diseases | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | lidocaine |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | lidocaine hydrochloride |
| MEDRT | D010146 | Pain | DISEASE | may_treat | lidocaine |
| MEDRT | D010146 | Pain | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D012772 | Shock, Septic | DISEASE | may_treat | epinephrine |
| MEDRT | D013614 | Tachycardia, Paroxysmal | DISEASE | may_treat | lidocaine |
| MEDRT | D013614 | Tachycardia, Paroxysmal | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | may_treat | epinephrine |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | may_treat | lidocaine |
| MEDRT | D018754 | Ventricular Dysfunction | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D014693 | Ventricular Fibrillation | DISEASE | may_treat | epinephrine |
| MEDRT | D014693 | Ventricular Fibrillation | DISEASE | may_treat | lidocaine |
| MEDRT | D014693 | Ventricular Fibrillation | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D018879 | Ventricular Premature Complexes | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D018879 | Ventricular Premature Complexes | DISEASE | may_treat | lidocaine |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | epinephrine |
| MEDRT | N0000009921 | Adrenergic beta1-Agonists | MOA | has_moa | epinephrine |
| MEDRT | N0000009922 | Adrenergic beta2-Agonists | MOA | has_moa | epinephrine |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | lidocaine |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | lidocaine hydrochloride |
| MEDRT | N0000008298 | Arterial Vasoconstriction | PE | has_pe | epinephrine |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | epinephrine |
| MEDRT | N0000008330 | Cardiac Rhythm Alteration | PE | has_pe | lidocaine |
| MEDRT | N0000008330 | Cardiac Rhythm Alteration | PE | has_pe | lidocaine hydrochloride |
| MEDRT | N0000008472 | Decreased Cardiac Muscle Organized Electrical Activity | PE | has_pe | lidocaine hydrochloride |
| MEDRT | N0000008472 | Decreased Cardiac Muscle Organized Electrical Activity | PE | has_pe | lidocaine |
| MEDRT | N0000009944 | Decreased Intraocular Aqueous Secretion | PE | has_pe | epinephrine |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | lidocaine |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | lidocaine hydrochloride |
| MEDRT | N0000009014 | Decreased Uterine Smooth Muscle Contraction or Tone | PE | has_pe | epinephrine |
| MEDRT | N0000009070 | Hemostasis Alteration | PE | has_pe | epinephrine |
| MEDRT | N0000178478 | Increased Blood Pressure | PE | has_pe | epinephrine |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine hydrochloride |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine |
| MEDRT | N0000009808 | Positive Chronotropy | PE | has_pe | epinephrine |
| MEDRT | N0000009809 | Positive Inotropy | PE | has_pe | epinephrine |
| MEDRT | N0000009820 | Pupillary Dilation | PE | has_pe | epinephrine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.005 MG/ML / 15 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | QUANTITY | 30 ML |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA089645 |
| CODES | VUID | 4005911 |
| NAMES | Prescribable Synonym | lidocaine HCl 1.5 % / EPINEPHrine 1:200,000 in 30 ML Injection |
| NAMES | Tallman Synonym | 30 ML EPINEPHrine 0.005 MG/ML / lidocaine hydrochloride 15 MG/ML Injection |
| NAMES | Tallman Synonym | lidocaine HCl 1.5 % / EPINEPHrine 1:200,000 per 30 ML Injection |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |